NCT06041750

Brief Summary

It is known that perioperative respiratory complications occur more often in obstructive sleep apnea syndrome (OSAS) patients during general anesthesia. Although there are prospective RCTs in this area, the need for further and larger studies remains due to the heterogenity of the results. Moreover, the incidence of postoperative pulmonary complications in OSAS patients undergoing surgery in Turkey and the predictive factors affecting the respiratory adverse events are uncertain. Therefore, in this prospective observational cohort study, it was aimed to determine the incidence of postoperative pulmonary complications and the predictor factors associated with patient, anesthesia and surgery in surgical patients with a confirmed or highly suspected OSAS diagnosis undergoing general anesthesia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 18, 2023

Completed
27 days until next milestone

Study Start

First participant enrolled

October 15, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

September 18, 2023

Status Verified

September 1, 2023

Enrollment Period

1.2 years

First QC Date

September 11, 2023

Last Update Submit

September 15, 2023

Conditions

Keywords

obstructive sleep apneapostoperative pulmonary complicationsgeneral anesthesia

Outcome Measures

Primary Outcomes (1)

  • postoperative pulmonary complications

    The rate of postoperative hypoxia (respiratory failure), atelectasis, pulmonary edema /embolus, aspiration, bronchospasm, respiratory infection / pneumonia, pleural effusion, pneumothorax, respiratory arrest will be measured

    Postoperative day 1, 2, 7 and 30.

Secondary Outcomes (4)

  • Predictive factors

    Postoperative day 1, 2, 7 and 30.

  • Non-invasive/invasive mechanical ventilation requirement

    Postoperative day 1, 2, 7 and 30.

  • Intensive care unit admission

    Postoperative day 1, 2, 7 and 30.

  • Mortality

    Postoperative day 30.

Study Arms (1)

OSAS patients with postoperative pulmonary complication

American Society of Anesthesiologists (ASA) physical status I-III adult patients age between 18-65 years undergoing elective surgery with general anesthesia and diagnosis of OSAS will be recruited in this study. In this patient group, the incidence of postoperative early-period and long-term pulmonary complications will be investigated.

Procedure: Elective surgical procedure under general anesthesia

Interventions

The incidence of postoperative pulmonary complications in OSAS patients undergoing elective surgery under general anesthesia will be determined.

OSAS patients with postoperative pulmonary complication

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

ASA status I-III adult patients age between 18-65 years undergoing elective surgery with general anesthesia and diagnosis of OSAS will be recruited in this study.

You may qualify if:

  • Age: 18-65 years
  • ASA physical status I-III
  • Preoperative OSAS diagnosis (with polysomnography or STOP-BANG questionnaire score)
  • Surgeries performed under general anesthesia
  • Endotracheal intubation facilitated by neuromuscular blockers

You may not qualify if:

  • ASA physical status IV or V
  • Planned admission to the ICU after surgery
  • Cardiac Surgery
  • Non-operating room anesthesia
  • Neuromuscular disease
  • Emergency or re-operational procedure
  • Laryngectomy
  • Pneumonectomy
  • Invasive airway access
  • Pregnancy
  • Outpatient surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cukurova University

Adana, Sariçam, 01100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructivePostoperative Complications

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Çiğdem Tütüncü, Prof. Dr.

    İstanbul University, Cerrahpaşa, Faculty of Medicine

    STUDY DIRECTOR
  • Demet Laflı Tunay, Dr.

    Çukurova University, Faculty of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Çiğdem Tütüncü, Prof. Dr.

CONTACT

Demet Laflı Tunay, Dr.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 11, 2023

First Posted

September 18, 2023

Study Start

October 15, 2023

Primary Completion

December 15, 2024

Study Completion

March 31, 2025

Last Updated

September 18, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

All data will be anonymized by the local researcher. Therefore, data collection will be pseudonymous and the patient's name will not appear on any case report form or other study document. All collected data will be kept confidential. This study will be conducted in accordance with the revision of the Declaration of Helsinki (2008). ICH-GCP will be strictly adhered to.

Locations